World Expert Education Session

(Photo: Dr Michael Aitkenhead, Senior Medical Advisor Haematology – Janssen; Sharna Moloney, Lymphoma Care Nurse Consultant; Dr Jason Butler; Prof Simon Rule; Donna Gairns, Lymphoma Care Nurse Consultant) 

Professor Simon Rule from the United Kingdom gave a special presentation about the latest treatments for follicular and mantle cell lymphoma in Brisbane on 23 October 2018.

We sincerley thank Prof Rule for his expertise, knowledge sharing, energy and time answering questions.

Special thanks to Board member Dr Jason Butler for being MC and adding Australian updates to the presentation, as well as our sponsors who supported this event for patients.

The presentation focused on

  • Current treatments for follicular and mantle cell lymphoma
  • What is new for follicular and mantle cell lymphoma
  • Your questions answered

This filmed education session is available to watch here  

About Professor Rule 

Professor Rule qualified from Nottingham medical school in 1987. He  trained in Haematology in London at the Westminster and Hammersmith  hospitals and also in Perth, Western Australia.

He is
currently a Consultant Haematologist at Plymouth Hospitals NHS Trust and Professor in Haematology at Plymouth University Peninsula School of Medicine and Dentistry. His major interests are lymphoma, leukaemia and new drug development. His specific area of interest is in mantle cell lymphoma and he has a research team looking at various aspects of this disease. Prof Rule is currently the Chief Investigator for a number of phase II
and III lymphoma studies being conducted at local, national and international level.

 

More information 

For further information on Follicular or Mantle Cell Lymphoma or to have your questions answered, please contact our Lymphoma Care Nurse team – nurse@lymphoma.org.au  or phone 1800 953 081.

Share This

Contact Lymphoma Australia Today!

Please note: Lymphoma Australia staff are only able to reply to emails sent in English language.

For people living in Australia, we can offer a phone translation service. Have your nurse or English speaking relative call us to arrange this.

Useful Definitions

  • Refractory: This means the lymphoma does not get better with treatment. The treatment didn’t work as hoped.
  • Relapsed: This means the lymphoma came back after being gone for a while after treatment.
  • 2nd line treatment: This is the second treatment you get if the first one didn’t work (refractory) or if the lymphoma comes back (relapse).
  • 3rd line treatment: This is the third treatment you get if the second one didn’t work or the lymphoma comes back again.
  • Approved: Available in Australia and listed by the Therapeutics Goods Administration (TGA).
  • Funded: Costs are covered for Australian citizens. This means if you have a Medicare card, you shouldn’t have to pay for the treatment.[WO7]

You need healthy T-cells to make CAR T-cells. For this reason, CAR T-cell therapy cannot be used if you have a T-cell lymphoma – yet.

For more information on CAR T-cells and T-cell lymphoma click here. 

Special Note: Although your T-cells are removed from your blood for CAR T-cell therapy, most of our T-cells live outside of our blood – in our lymph nodes, thymus, spleen and other organs.